The Butler County commissioners on Wednesday will vote on the accepting $9.523 million from the state's proposed $1.07 billion settlement with several opioid manufacturers.

The proposed settlement involves several, but not all, of the defendants in the national opioid class action proceedings. The defendants who are part of the proposed settlement with the state are McKesson Corporation, Cardinal Health, Amerisource Bergen Corp., Johnson & Johnson, Janssen Pharmaceuticals, and Ortho-McNeil-Janssen Pharmaceuticals.

The proposed settlement would result in the creation of the Pennsylvania Opioid Misuse and Addiction Abatement Trust. The trust would govern the disbursement of the settlement funds received by the state and the political subdivisions, which include the county, in the state who were parties to the class action proceeding.

The trust would allocate 15% of the settlement amount to the state; 70% to local governments and 15% to the litigating subdivisions and agencies who participated in the class action. If all goes as planned, the state should receive approximately $1.07 billion. The share of that going to the counties would be approximately $700 million, and the county's potential share would be about $9.523 million.

The settlement requires municipalities with populations of 10,000 or more in the counties to approve the settlement. Those municipalities include Butler City, Butler Township, Cranberry Township and Adams Township.

A portion of this story is shared as a digital media exclusive. Subscribers can read the full story online tomorrow or in tomorrow's print edition of the paper.